Most Dementia Patients Get Drugs of Questionable Benefit
This article is for subscribers only.
More than half of patients with advanced dementia regularly are given drugs of questionable benefit at a monthly cost of about $272, researchers said.
The report, published today by the journal JAMA Internal Medicine, reviewed treatments for 5,406 nursing home residents, based on standards set by a medical panel.